UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy

The Journal of nuclear medicine (1978), 2016-01, Vol.57 (1), p.151-162

2016

Volltextzugriff (PDF)

Dosimetric Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Squamous Cell Carcinoma of the Head and Neck

International journal of radiation oncology, biology, physics, 2010-02, Vol.76 (2), p.403-409

2010

Volltextzugriff (PDF)

Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Locally Advanced Head-and-Neck Cancer

International journal of radiation oncology, biology, physics, 2009-02, Vol.73 (2), p.410-415

2009

Volltextzugriff (PDF)

MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy

Journal of Nuclear Medicine, 2010-02, Vol.51 (2), p.311-328

2010

Volltextzugriff (PDF)

Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck

Head & neck, 2008-03, Vol.30 (3), p.281-288

2008

Volltextzugriff (PDF)

MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response--Implications for Radionuclide Therapy

Journal of Nuclear Medicine, 2008-11, Vol.49 (11), p.1884-1899

2008

Volltextzugriff (PDF)

Mucositis-Related Morbidity and Resource Utilization in Head and Neck Cancer Patients Receiving Radiation Therapy With or Without Chemotherapy

Journal of pain and symptom management, 2009-10, Vol.38 (4), p.522-532

2009

Volltextzugriff (PDF)

Phase I Study of Anti–Epidermal Growth Factor Receptor Antibody Cetuximab in Combination With Radiation Therapy in Patients With Advanced Head and Neck Cancer

Journal of clinical oncology, 2001-07, Vol.19 (13), p.3234-3243

2001

Volltextzugriff (PDF)

Biological Effective Radiation Dose for Multiple Myeloma Palliation

Advances in radiation oncology, 2023-07, Vol.8 (4), p.101214-101214, Article 101214

2023

Volltextzugriff (PDF)

Phase II Study of Palifermin and Concurrent Chemoradiation in Head and Neck Squamous Cell Carcinoma

Journal of clinical oncology, 2008-05, Vol.26 (15), p.2489-2496

2008

Volltextzugriff (PDF)

Locoregionally Advanced Head and Neck Cancer Treated With Primary Radiotherapy: A Comparison of the Addition of Cetuximab or Chemotherapy and the Impact of Protocol Treatment

International journal of radiation oncology, biology, physics, 2008-07, Vol.71 (3), p.676-681

2008

Volltextzugriff (PDF)

Margin on Gross Tumor Volume and Risk of Local Recurrence in Head-and-Neck Cancer

International journal of radiation oncology, biology, physics, 2010-01, Vol.76 (1), p.164-168

2010

Volltextzugriff (PDF)

Predictors of Distant Brain Recurrence for Patients With Newly Diagnosed Brain Metastases Treated With Stereotactic Radiosurgery Alone

International journal of radiation oncology, biology, physics, 2008, Vol.70 (1), p.181-186

2008

Volltextzugriff (PDF)

Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant

Bone marrow transplantation (Basingstoke), 2018-10, Vol.53 (10), p.1345-1348

2018

Volltextzugriff (PDF)

Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma

Blood, 2004-07, Vol.104 (1), p.227-236

2004

Volltextzugriff (PDF)

Brief Overview of Preclinical and Clinical Studies in the Development of Intraperitoneal Radioimmunotherapy for Ovarian Cancer

Clinical cancer research, 2007-09, Vol.13 (18), p.5643s-5645s

2007

Volltextzugriff (PDF)

Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab

American journal of clinical oncology, 2018-07, Vol.41 (7), p.716-721

2018

Volltextzugriff (PDF)

Longitudinal evaluation of the oral mucositis weekly questionnaire‐head and neck cancer, a patient‐reported outcomes questionnaire

Cancer, 2007-05, Vol.109 (9), p.1914-1922

2007

Volltextzugriff (PDF)

Enhanced Apoptosis With Combination C225/Radiation Treatment Serves as the Impetus for Clinical Investigation in Head and Neck Cancers

Journal of clinical oncology, 2000-11, Vol.18 (suppl 1), p.47s-53s

2000

Volltextzugriff (PDF)

Ongoing investigations and new uses of radioimmunotherapy in the treatment of non-Hodgkin’s lymphoma

International journal of radiation oncology, biology, physics, 2006-10, Vol.66 (2), p.S23-S29

Meredith, Ruby F.

2006

Volltextzugriff (PDF)

Rationales, evidence, and design considerations for fractionated radioimmunotherapy

Cancer, 2002-02, Vol.94 (4), p.1332-1348

2002

Volltextzugriff (PDF)

Targeted radionuclide therapy

Medical physics (Lancaster), 2008-07, Vol.35 (7), p.3062-3068

2008

Volltextzugriff (PDF)

Risks to Normal Tissues From Radionuclide Therapy

Seminars in nuclear medicine, 2008-09, Vol.38 (5), p.347-357

2008

Volltextzugriff (PDF)

Pretargeted radioimmunotherapy

International journal of radiation oncology, biology, physics, 2006-01, Vol.66 (2), p.S57-S59

2006

Volltextzugriff (PDF)

Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Postmenopausal Women With Newly Diagnosed Estrogen Receptor— or Progesterone Receptor—Positive Breast Cancer

Clinical breast cancer, 2010-08, Vol.10 (4), p.275-280

2010

Volltextzugriff (PDF)

1 – 25 von 242

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(220)
Mit Volltextzugriff
(194)

Publikationsform

Sprache

Englisch
(241)

Erscheinungsjahr

n.n

Thema

Science & Technology
(137)
Life Sciences & Biomedicine
(134)
Humans
(127)
Female
(85)
Oncology
(69)
Middle Aged
(65)
Radiology, Nuclear Medicine & Medical Imaging
(64)
Male
(61)
Aged
(54)
Biological And Medical Sciences
(47)
Medical Sciences
(47)
Adult
(44)
Radiotherapy Dosage
(32)
Animals
(27)
Radioimmunotherapy
(26)
Radioimmunotherapy - Methods
(25)
Aged, 80 And Over
(23)
Dosimetry
(22)
Antibodies, Monoclonal - Therapeutic Use
(21)
Mice
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy

Dosimetric Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Squamous Cell Carcinoma of the Head and Neck

Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Locally Advanced Head-and-Neck Cancer

MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy

Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck

MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response--Implications for Radionuclide Therapy

Mucositis-Related Morbidity and Resource Utilization in Head and Neck Cancer Patients Receiving Radiation Therapy With or Without Chemotherapy

Phase I Study of Anti–Epidermal Growth Factor Receptor Antibody Cetuximab in Combination With Radiation Therapy in Patients With Advanced Head and Neck Cancer

Biological Effective Radiation Dose for Multiple Myeloma Palliation

Phase II Study of Palifermin and Concurrent Chemoradiation in Head and Neck Squamous Cell Carcinoma

Locoregionally Advanced Head and Neck Cancer Treated With Primary Radiotherapy: A Comparison of the Addition of Cetuximab or Chemotherapy and the Impact of Protocol Treatment

Margin on Gross Tumor Volume and Risk of Local Recurrence in Head-and-Neck Cancer

Predictors of Distant Brain Recurrence for Patients With Newly Diagnosed Brain Metastases Treated With Stereotactic Radiosurgery Alone

Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant

Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma

Brief Overview of Preclinical and Clinical Studies in the Development of Intraperitoneal Radioimmunotherapy for Ovarian Cancer

Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab

Longitudinal evaluation of the oral mucositis weekly questionnaire‐head and neck cancer, a patient‐reported outcomes questionnaire

Enhanced Apoptosis With Combination C225/Radiation Treatment Serves as the Impetus for Clinical Investigation in Head and Neck Cancers

Ongoing investigations and new uses of radioimmunotherapy in the treatment of non-Hodgkin’s lymphoma

Rationales, evidence, and design considerations for fractionated radioimmunotherapy

Targeted radionuclide therapy

Risks to Normal Tissues From Radionuclide Therapy

Pretargeted radioimmunotherapy

Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Postmenopausal Women With Newly Diagnosed Estrogen Receptor— or Progesterone Receptor—Positive Breast Cancer

Suchergebnisse filtern